It is well-known that dyslipidaemias are greatly underdiagnosed and undertreated in different European countries, even after the publication of different large clinical trials that assessed the safety and efficacy of the available antihyperlipidaemic drugs. This assertion interests both the general population [1] and those subjects who would more strongly benefit from the antihyperlipidaemic treatment on the basis of their class of cardiovascular risk.
Cicero, A.F.G., Forghieri, M., Arletti, R. (2003). Hypercholesterolemia underdiagnosis and undertreatment in psychiatric patients in Italy. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 18(4), 373-374.
Hypercholesterolemia underdiagnosis and undertreatment in psychiatric patients in Italy
Cicero AFG
Primo
Conceptualization
;
2003
Abstract
It is well-known that dyslipidaemias are greatly underdiagnosed and undertreated in different European countries, even after the publication of different large clinical trials that assessed the safety and efficacy of the available antihyperlipidaemic drugs. This assertion interests both the general population [1] and those subjects who would more strongly benefit from the antihyperlipidaemic treatment on the basis of their class of cardiovascular risk.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
